TIDMAMP

RNS Number : 3582Y

Amphion Innovations PLC

05 December 2017

AMPHION INNOVATIONS PLC

("Amphion" or "the Company")

Share Issuance

London and New York, Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, today announces that the Company has issued 1,664,659 ordinary shares, representing 0.80% of the enlarged issued share capital, to a holder ("Note Holder") of the Convertible Promissory Notes December 2008 - December 2017 (the "CPN"). The Note Holder is converting its CPN Holding of GBP133,172.76 into Amphion ordinary shares at 8 pence per share.

An application has been made for the new ordinary shares to be admitted to trading on AIM. Admission of the 1,664,659 new ordinary shares, ranking pari passu with the existing ordinary shares, is expected on 8 December 2017. Following this allotment, the total issued share capital of the Company will be 209,175,888 ordinary shares with each ordinary share holding one voting right. This figure may be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR").

For further information please contact:

 
 Amphion Innovations                           Tel: +1 (212) 210 6224 
 Charlie Morgan 
 
 Panmure Gordon Limited (Nominated                     Tel: +44 (0)20 
  Adviser and Corporate Broker)                             7886 2500 
 Freddy Crossley / Ryan McCarthy 
  (Corporate Finance) 
 Charlie Leigh-Pemberton 
  (Corporate Broking) 
 
 Northland Capital Partners                       Tel: +44 (0)20 3861 
  Limited (Joint Corporate Broker)                               6625 
 Patrick Claridge / David 
  Hignell (Corporate Finance) 
 John Howes (Corporate 
  Broking) 
 
 Walbrook PR                                 Tel: +44 (0)20 7933 8780 
                                                                   or 
 Mike Wort/ Paul McManus                       amphion@walbrookpr.com

About Amphion Innovations plc

Amphion Innovations is a developer of medical, life science and technology businesses. We use our extensive experience in company building to invest and build shareholder value in high growth companies in the US and UK. Amphion has significant shareholding in a small number of Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies.

On the web: www.amphionplc.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

IOELFFFIFDLSIID

(END) Dow Jones Newswires

December 05, 2017 02:00 ET (07:00 GMT)

Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Amphion Innovations Charts.
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Amphion Innovations Charts.